title: Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream.
authors.forename: Sonia
authors.initials: S
authors.lastname: Segura
authors.forename: David
authors.initials: D
authors.lastname: Romero
authors.forename: Cristina
authors.initials: C
authors.lastname: Carrera
authors.forename: Pilar
authors.initials: P
authors.lastname: Iranzo
authors.forename: Teresa
authors.initials: T
authors.lastname: Estrach
mesh_terms: D000287:Administration, Topical; D000328:Adult; D003876:Dermatitis, Atopic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007617:Kaposi Varicelliform Eruption / Q000150:complications / Q000276:immunology / Q000473:pathology*; D008297:Male; D009824:Ointments; D016559:Tacrolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D007166:Immunosuppressive Agents; D009824:Ointments; C117268:pimecrolimus; D016559:Tacrolimus